Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Jan 14, 2021 9:52pm
253 Views
Post# 32303565

MASSIVE RALLY Pending for MEDV: $ 70 billion is AVAILABLE.

MASSIVE RALLY Pending for MEDV: $ 70 billion is AVAILABLE.Now you know why Canaccord was willing to give MEDV $ 5 million bought deal to MEDV - eyes closed.

They knew of this $ 70 BILLION pot of money that is available to MEDV.

($50 billion testing  and $ 20 billion vaccination)....

We are a $ 20 per share stock in the marking.   If they can take 5% of this it is $ 3.5 billion in sales. 

My or my......the MEDV vault is going to fill up with CASH.

This ferocious rally is start when bought deal closes on January 26th as it has to be approved by regulators and, price cannot be too high compared to offering.   A big discount is normal but, not a huge discount.   Otherwise, Canaccord will have to pay us much more. 

MPO
<< Previous
Bullboard Posts
Next >>